Top 20 Edimer Pharmaceuticals investors
The most complete profiles first. Showing 20 of 20.
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Alain NicodVerified
Venture Capital, Private Equity Firm · Switzerland
Health CareHospitalsCryptocurrencyCRMPortfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more
Verified email available
David MottVerified
Venture Capital, Angel/Individual, Investor · United States
SeedPre-SeedEnterprise SoftwareBiotechnologyHealth and Hospital ServicesConsumer InternetPortfolio: Nightstar Therapeutics, Ardelyx, Cydan, Adaptimmune and 4 more
Verified email available
Jason P. HaflerVerified
Corporate Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Verified email available
Laia CrespoVerified
Venture Capital, Corporate Venture Capital, Investor · France
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Verified email available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Mark Levin
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceEducationPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Neil Exter
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Arnd Kaltofen
Venture Capital, Private Equity Firm · Switzerland
Health CareHospitalsCryptocurrencyCRMPortfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more
Contact details available
Benedikt Luhmann
Venture Capital · Switzerland
Health CareHospitalsCryptocurrencyCRMPortfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more
Contact details available
Daniel Mansuri
Corporate Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Contact details available
Diego Braguglia
Venture Capital, Private Equity Firm · Switzerland
Health CareHospitalsCryptocurrencyCRMPortfolio: HighLife, Activaero, L.E.S.S., ESBATech and 42 more
Contact details available
Kelly Moynihan
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Walter Kowtoniuk
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
William Motley
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Edimer Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 20 Edimer Pharmaceuticals investors. 8 of them (40%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (9) and Corporate Venture Capital Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Edimer Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (9) and Pre-Seed (1).
Where are Edimer Pharmaceuticals investors based?
Most are based in the United States (15), Switzerland (4) and France (1).
Which companies have Edimer Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Bluebird Bio (15), CytomX Therapeutics (12), Maze Therapeutics (12), Faze Medicines (12) and Rhythm Pharmaceuticals (12).
How do I contact Edimer Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.